FOLH1 and prostate carcinoma: Although prostate cancer cells express certain tissue-restricted antigens (e.g., PSA, prostate-specific membrane antigen [PSMA], and prostatic acid phosphatase [PAP]), these antigens alone rarely elicit sufficiently robust T-cell responses to overcome entrenched immunosuppressive pressures [5].